Latest News

Latest News

News from the World Hepatitis Alliance

WHO’s first Global Hepatitis Report sets baseline to measure progress towards the elimination of viral hepatitis by 2030

21 Apr 2017 Tara Farrell

London, 21 April 2017, The World Hepatitis Alliance today welcomes the publication of the first-ever Global Hepatitis Report by the World Health Organization (WHO). The report comes as a follow-up to WHO’s Global Strategy on Viral Hepatitis, which set a goal of eliminating viral hepatitis as a public health threat by 2030....

ZERO DISCRIMINATION DAY: FEAR AND IGNORANCE ROBS PEOPLE OF JOBS, EDUCATION OPPORTUNITIES, FRIENDSHIPS AND RELATIONSHIPS

1 Mar 2017 Bridie Taylor

People living with viral hepatitis are subject to stigma and discrimination in almost every aspect of their lives. Fear and ignorance have robbed...

World Day of Social Justice: fighting for our right to health

20 Feb 2017 Tara Farrell

By Raquel Peck By the time you finish reading this blog, a man, woman or child will have died from viral hepatitis; a disease which can either be...

New World Hepatitis Alliance President announced

26 Jan 2017 Bridie Taylor

Michael Ninburg appointed as WHA President Today, the World Hepatitis Alliance (WHA) Executive Board announced that, following a comprehensive...

Elimination to take centre stage at APASL 2017

24 Jan 2017 Bridie Taylor

The elimination of viral hepatitis to dominate discussions at the 26th Conference of the Asian Pacific Association for the Study of the Liver (APASL...

Industry and civil Society unite to help deliver hepatitis C medication in low-and middle-income countries

18 Jan 2017 Tara Farrell

Today, MasterCard signed a Memorandum of Understanding (MoU) with Gilead Sciences, Inc. to explore, in a pilot programme, the potential of using the...

India’s young filmmakers give a global voice to viral hepatitis survivors

14 Dec 2016 Tara Farrell

Today, media charity tve today launches four powerful films that give voice to five individuals in India who have survived viral hepatitis, one of...

Leave no-one behind

2 Dec 2016 Tara Farrell

On 3rd December, patients across the globe will unite to mark Patient Solidarity Day and reaffirm that patient-centred universal health coverage is...

HIV coinfection more than triples the risk of liver disease, liver failure and liver-related death from viral hepatitis

1 Dec 2016 Bridie Taylor

On World AIDS Day, the World Hepatitis Alliance calls for increased recognition of viral hepatitis and HIV coinfections London, 1 December 2016 –...

New WHA Executive Board announced

28 Nov 2016 Bridie Taylor

Our voting members have spoken and the votes have been counted! Following a fiercely contested election, we are delighted to announce our new...

WHO launches first-ever global report on access to hepatitis C treatment

27 Oct 2016 Tara Farrell

New report from the World Health Organization (WHO) released today shows how political will, civil society advocacy and pricing negotiations are...

Launch of World Hepatitis Day 2016 Report

19 Oct 2016 Tara Farrell

On 28 July 2016, patients, governments, organisations and many others participated the most successful World Hepatitis Day (WHD) to date, with 174...

New database sheds light on generic hep C drugs in low-and middle-income countries and how to access them

13 Oct 2016 Bridie Taylor

To provide information on the intellectual property status of priority medicines in 101 low-and middle-income countries, the Medicines Patent Pool (...

Interested in leading a global organisation in the fight to eliminate viral hepatitis?

15 Sep 2016 Bridie Taylor

The World Hepatitis Alliance (WHA) is seeking nominations for two key offices; President-Elect and Regional Executive Board Members, to drive action...

Europe Adopts Regional Action Plan to Eliminate Viral Hepatitis

14 Sep 2016 Tara Farrell

Today, representatives from the 53 countries in the WHO European Region adopted the first-ever Action Plan for viral hepatitis. The Action Plan,...

CHANGE OF DATE: WORLD HEPATITIS SUMMIT 2017

12 Sep 2016 Tara Farrell

Due to unforeseen circumstances, the Committee of the World Hepatitis Summit - comprising the World Hepatitis Alliance; World Health Organization and...

100 ACTIVISTS STAGE A “DIE-IN” TO SEND A POWERFUL MESSAGE TO WORLD LEADERS TO ELIMINATE VIRAL HEPATITIS

28 Jul 2016 Tara Farrell

On World Hepatitis Day, the World Hepatitis Alliance and The Hepatitis C Trust, held the first hepatitis “die-in” at Piccadilly Circus in London to...

Globally, 95% of people living with a cancer-causing illness are unaware

28 Jul 2016 Bridie Taylor

On World Hepatitis Day, the World Hepatitis Alliance is calling for a dramatic scale up in viral hepatitis testing to reduce liver cancer deaths...

Treatment of hepatitis C has more than doubled since 2013. Yet 99% of people are still being denied the life-saving cure

28 Jul 2016 Bridie Taylor

On World Hepatitis Day, the World Hepatitis Alliance is calling for a dramatic scale up in testing and treatment across all countries to reduce the...

Viral hepatitis is the 7th leading killer worldwide, killing more people than HIV, TB or malaria

7 Jul 2016 Tara Farrell

Viral hepatitis has become the seventh leading cause of death and disability in the world, killing more people in a year than HIV/AIDs, tuberculosis...

Pages

News from infohep

Generic hepatitis C drugs continue to produce high cure rates

24 Apr 2017 Keith Alcorn
Treatment with generic versions of direct-acting antiviral drugs continues to produce similar cure rates to those reported in clinical trials, Dr...

HCV treatment allows one in four people to come off the transplant waiting list

24 Apr 2017 Keith Alcorn
Around one in four people with hepatitis C and decompensated cirrhosis came off the transplant waiting list in Europe after direct-acting antiviral...

Nivolumab increases survival for people with advanced liver cancer

22 Apr 2017 Liz Highleyman
The checkpoint inhibitor nivolumab (Opdivo) produced durable responses, prolonged overall survival, and was generally well tolerated as a treatment...

Children with hepatitis C respond well to sofosbuvir/ledipasvir

22 Apr 2017 Liz Highleyman
Almost all children with hepatitis C, aged 6 to 11 years, who were treated with a half-strength tablet of sofosbuvir/ledipasvir were cured, which is...

AbbVie combination cures 97% of genotype 3 hepatitis C

21 Apr 2017 Keith Alcorn
AbbVie's pangenotypic direct-acting antiviral combination of two drugs cured 95% of people with early-stage genotype 3 hepatitis C virus (HCV...

New AbbVie hepatitis C combination cures 99% of people with cirrhosis

21 Apr 2017 Keith Alcorn
A new pangenotypic direct-acting antiviral combination developed by AbbVie is highly effective in curing hepatitis C in people with cirrhosis,...

Direct-acting antivirals for hepatitis C not linked to higher liver cancer risk in most studies

21 Apr 2017 Liz Highleyman
People with hepatitis C who take treatment with direct-acting antivirals (DAAs) do not appear to have a higher risk of developing liver cancer...

Curing hepatitis C reduces cardiovascular risk

20 Apr 2017 Keith Alcorn
Curing hepatitis C reduces the risk of cardiovascular events in people with compensated cirrhosis, a large French study presented this week at the...

European HCV treatment access survey shows big variations in eligibility

20 Apr 2017 Keith Alcorn
England, Malta, Slovakia, Hungary and Croatia have the tightest restrictions on who can receive direct-acting antiviral (DAA) treatment for hepatitis...

Antibiotic prophylaxis reduces the risk of short-term death in people with decompensated cirrhosis

20 Apr 2017 Keith Alcorn
Long-term prophylaxis with the antibiotic norfloxacin significantly reduced the incidence of deaths in people with decompensated cirrhosis over a six...